Anaphylaxis

Top Story

Advocacy group shines a light on food allergy awareness

Advocacy group shines a light on food allergy awareness
May 15, 2017

On Sunday, May 14, the Empire State Building was illuminated in teal in honor of the 20th annual Food Allergy Awareness Week, intended to educate the public regarding the serious consequences of food allergy reactions, identify symptoms and respond accordingly in an emergency.

“Seeing one of the most famous buildings in the world shining in teal for food allergy awareness is a fantastic way to observe Food Allergy Awareness Week,” James R. Baker, Jr., MD, CEO of Food Allergy Research & Education (FARE), said in a press release. “In 20 years, awareness about food allergies has risen, but we still have more work to do to increase understanding and foster respect and empathy for this often-misunderstood disease.”

In the Journals

Supervised self-injected epinephrine tutorials improved food-allergic patient, parent comfort levels

April 13, 2017
Adolescents with severe food allergies and their parents reported less anxiety about self-administering epinephrine injections after practicing with an empty syringe in…
In the Journals

EpiPen settlement proposal not enough, researchers say

March 28, 2017
The $465 million settlement proposed by Mylan, the manufacturer of the epinephrine autoinjector EpiPen, to resolve its misclassification of EpiPen as a generic drug for…
Meeting News

Web-based education for asthma, anaphylaxis improved quality of care

March 9, 2017
ATLANTA — Both pediatricians and allergists demonstrated improved quality of care for patients with asthma and anaphylaxis following web-based education program

Advocacy group shines a light on food allergy awareness

May 15, 2017
On Sunday, May 14, the Empire State Building was illuminated in teal in honor of the 20th annual Food Allergy Awareness Week, intended to educate

In the Journals

Supervised self-injected epinephrine tutorials improved food-allergic patient, parent comfort levels

April 13, 2017
Adolescents with severe food allergies and their parents reported less anxiety about self-administering epinephrine injections after practicing with…

In the Journals

EpiPen settlement proposal not enough, researchers say

March 28, 2017
The $465 million settlement proposed by Mylan, the manufacturer of the epinephrine autoinjector EpiPen, to resolve its misclassification of EpiPen as…

Meeting News

Web-based education for asthma, anaphylaxis improved quality of care

March 9, 2017
ATLANTA — Both pediatricians and allergists demonstrated improved quality of care for patients with asthma and anaphylaxis following web-based

Meeting News

Anaphylactic events in schools more common in classrooms than cafeterias

March 6, 2017
ATLANTA — Among the anaphylactic events reported in United States schools, nearly half occurred in the classroom rather than the cafeteria or

Meeting News

Online epinephrine autoinjector costs vary significantly

March 6, 2017
ATLANTA — Significant online cost differences among epinephrine autoinjector devices do not correspond with incremental benefit, according to…

Meeting News

Asthma, anaphylactic emergencies indistinguishable by smartphone voice assistants

March 6, 2017
ATLANTA — Patients who used smartphone-based voice assistants were not able to receive complete or consistent feedback from the program when

Perspective

AUVI-Q epinephrine auto-injector manufacturer addresses price concerns

January 19, 2017
The epinephrine auto-injector AUVI-Q, used for the emergency treatment of anaphylaxis, will be available starting Feb. 14, kaléo, its

Meeting NewsPerspective

Majority of non-nurse school staff correctly identified anaphylaxis treatment protocol

November 14, 2016
While most surveyed non-nurse school staff correctly identified the protocol to treat severe allergic reactions among students, few felt confident in…

FDA News

FDA grants fast track designation to Viaskin Milk for milk allergy

September 26, 2016
The FDA granted fast track designation to an investigational treatment for pediatric patients aged two years and older with immunoglobulin E-mediated…

More Headlines »
Advertisement
Advertisement